AMA and ROFIM unveil the first global surgical teleassistance solution
01 Febrero 2024 - 1:00AM
Press releaseFOR IMMEDIATE
RELEASE
AMA and ROFIM unveil the first global
surgical teleassistance solution
Rennes, France - February 1, 2024
- AMA CORPORATION PLC ("AMA") (ISIN GB00BNKGC5 - mnemo
ALAMA), and ROFIM, developers of telemedicine software, announce
the launch of a global solution for surgical remote assistance,
covering the pre-, per- and post-operative phases.
This integrated solution, accessible via a web
browser, extends from tele-expertise to remote expert assistance.
It enables medical centers to request a specialist opinion from a
reference center by transmitting the patient's medical file and
preoperative images (CT scans, MRIs, etc.) and organizing
inter-center multidisciplinary meetings. During the operation,
thanks to assisted reality, the surgeon can share his or her point
of view in real-time with a remote expert. The expert receives
various video streams simultaneously (connected glasses,
third-party cameras, endoscopy column, etc.) and benefits from
advanced functionalities such as video pointing, annotations, live
document sharing, zoom, and brightness and contrast control.
According to Dr. Daniel Pietrasz, surgeon at the
Paul-Brousse AP-HP hospital, this encrypted and secure solution,
with no data storage, represents a considerable advantage for
requesting centers, expert centers, and patients. "For requesting
centers, it means a transfer of expertise and maintenance of
activity, especially for complex cases. For the expert centers,
it's an opportunity to extend their influence beyond geographical
borders and to provide a second opinion for complex surgical
situations such as transplantation and the use of perfusion
machines. As for patients, they benefit from an exchange of
surgical expertise to anticipate the key elements of pre-, intra-,
and post-operative management." The solution can also be used
within hospitals to assist junior surgeons in the operating
theatre.
This innovative solution, the result of
collaboration between AMA and ROFIM, has its origins in a long-term
partnership with the "Bloc OPératoire Augmenté" innovation chair,
known as BOPA (AP-HP, Mines Telecom Institut, University of Paris
Saclay). It has already been used in several healthcare
establishments, including BOPA, and deployed by the ARS and GRADeS
in French Guiana and Martinique. According to Pr. Éric Vibert,
transplant surgeon at the Paul-Brousse AP-HP hospital and founder
of the BOPA Innovation Chair, the emergence of this solution under
the impetus of Dr. Daniel Pietrasz is a fine illustration of the
dynamic transformation of operating room practices with the arrival
of new digital tools, particularly as it encourages new forms of
cooperation between centers. As such, it is in line with the major
orientations of the France 2030 plan, launched by the French
government to support and accelerate innovation in healthcare and
the continuous improvement of care.
Watch the video interview here.
About AMA
AMA is a publisher and integrator of secure
applications designed for telemedicine and connected field workers.
We use cutting-edge technologies such as assisted reality (aR) and
Artificial Intelligence (AI) to enable remote assistance and the
digitization of inspections and work instructions. Our XpertEye
suite of secure applications enables customers to improve
productivity, accelerate resolution time, retain knowledge, and
reduce their carbon footprint.
AMA already equips numerous emergency services
and healthcare facilities with XpertEye, as well as MedTech
companies such as Alcon, Boston Scientific, Corcym, and Stryker,
addressing use cases such as teleregulation, teleconsultation, and
surgical tele-assistance.
We are B Corp certified, affirming our
dedication to meeting the highest standards of social and
environmental performance, transparency, and
accountability. We have a global presence, with offices in
Europe, the APAC region, and the USA, enabling us to support our
customers in all time zones and regions of the world. AMA is listed
on Euronext Growth Paris (ISIN GB00BNKGZC51- mnemonic ALAMA).
AMA is a member of the French HealthCare
Association.
About ROFIM
ROFIM is a French company specialized in
telemedicine software publishing since 2018. It is co-directed by
Dr. David Bensoussan, cardiovascular surgeon and Émilie Mercadal
(CEO) supported by a committeé of experts made up of 34 healthcare
professionals.
It offers more than 30,000 doctors, 900
healthcare establishments (including AP-HP, AP-HM), paramedical
staff, and patients a unique platform for managing in SAAS mode
(via a simple web and mobile browser) teleconsultations,
tele-expertise, Multidisciplinary Concertation Meetings,
collaborative diagnostics, instant messaging, totally secure file
transfer including medical imaging.
ROFIM is a multi-disciplinary platform that
brings together the expertise of practitioners, dedicated analysis
technology, and medical imaging to deliver the fastest possible
diagnosis to patients.
AMA (EU:ALAMA)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
AMA (EU:ALAMA)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
